Resultats de la cerca - Javier Alcácer
- Mostrar 1 - 6 resultats de 6
-
1
Glucocorticoid Receptor Knockdown Decreases the Antioxidant Protection of B16 Melanoma Cells: An Endocrine System-Related Mechanism that Compromises Metastatic Cell Resistance to V... per Obrador, Elena, Valles, Soraya L., Benlloch, María, Sirerol, J. Antoni, Pellicer, José A., Alcácer, Javier, Coronado, Javier Alcácer-F., Estrela, José M.
Publicat 2014Text -
2
Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transi... per Lara Milián, Manuel Mata, Javier Alcácer, María Oliver-Ferrándiz, María Sancho‐Tello, José Javier Martı́n de Llano, Carlos Camps, José M. Galbis, Julián Carretero, Carmen Cardá
Publicat 2020Artigo -
3
Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells <i>In Vivo</i>: A Physiological Glucocorticoids- and Nrf2-Dependent Mechanism per María Benlloch, Elena Obrador, Soraya L. Vallés, María L. Rodríguez, J. Antoni Sirerol, Javier Alcácer, José A. Pellicer, Rosario Salvador‐Palmer, Concha Cerdá, Guillermo T. Sáez, José M. Estrela
Publicat 2015Artigo -
4
CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC per Jeffrey H. Becker, Yandi Gao, Margaret Soucheray, Inés Pulido, Eiki Kikuchi, María L. Rodríguez, Rutu Gandhi, Aránzazu Lafuente-Sanchis, Miguel Aupí, Javier Alcácer Fernández-Coronado, Paloma Martín-Martorell, Antonio Cremades, José M. Galbis, Javier Alcácer, Camilla L. Christensen, Patricia Simms, Ashley Hess, Hajime Asahina, Michael Kahle, Fátima Al‐Shahrour, Jeffrey A. Borgia, Agustín Lahoz, Amelia Insa, Óscar Juan, Pasi A. Jänne, Kwok‐Kin Wong, Julián Carretero, Takeshi Shimamura
Publicat 2019Artigo -
5
Endothelin-1-mediated Drug Resistance in EGFR-mutant NSCLC per Pulido, Inés, Ollosi, Stephen, Aparisi, Salvador, Becker, Jeffrey H., Aliena-Valero, Alicia, Benet, Marta, Rodríguez, María L., López, Adrián, Tamayo-Torres, Eva, Chuliá-Peris, Lourdes, García-Cañaveras, Juan Carlos, Soucheray, Margaret, Dalheim, Annika V., Salom, Juan B., Qiu, Wei, Kaja, Simon, Fernández-Coronado, Javier Alcácer, Alandes, Sandra, Alcácer, Javier, Al-Shahrour, Fátima, Borgia, Jeffrey A., Juan, Oscar, Nishimura, Michael I., Lahoz, Agustín, Carretero, Julián, Shimamura, Takeshi
Publicat 2020Text -
6
CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC. per Becker, Jeffrey H., Gao, Yandi, Soucheray, Margaret, Pulido, Ines, Kikuchi, Eiki, Rodríguez, María L., Gandhi, Rutu, Lafuente-Sanchis, Aranzazu, Aupí, Miguel, Fernández-Coronado, Javier Alcácer, Martín-Martorell, Paloma, Cremades, Antonio, Galbis-Caravajal, José M., Alcácer, Javier, Christensen, Camilla L., Simms, Patricia, Hess, Ashley, Asahina, Hajime, Kahle, Michael P., Al-Shahrour, Fatima, Borgia, Jeffrey A., Lahoz, Agustín, Insa, Amelia, Juan, Oscar, Jänne, Pasi A., Wong, Kwok-Kin, Carretero, Julian, Shimamura, Takeshi
Publicat 2019Text
Eines de cerca:
Matèries relacionades
Biology
Cancer research
Medicine
Biochemistry
Cancer
Chemistry
Internal medicine
Pharmacology
Receptor
A549 cell
Agonist
Antioxidant
Biotechnology
Cannabidiol
Cannabinoid
Cannabinoid receptor
Cannabinoid receptor type 2
Cannabis
Cell
Cell biology
Cell growth
Chemokine
Chemokine receptor
Corticosterone
EGFR inhibitors
Endocrinology
Enzyme
Epidermal growth factor receptor
Epithelial–mesenchymal transition
Genetics